HopeStage
Back to all studies
Enrolling By InvitationNCT05852860

A Patient-Oriented Research Mentoring Program in Tobacco Dependence and Implementation Science Research

Interventional studyUnited StatesAddiction
The study in practice

Understand this study

Listed locations
PhiladelphiaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 1, 2023
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
500
Sponsor
Abramson Cancer Center at Penn Medicine
Sponsor type
Pharmaceutical company
Study type
Other
Intervention type
Other
Locations
United States
Age range
Not clearly listed
Official registry ID
NCT05852860
Official title
Show the full official title

A Patient-Oriented Research Mentoring Program in Tobacco Dependence and Implementation Science Research: Improving Tobacco Treatment Rates for People Living With HIV Who Smoke

Recruitment & locations

By invitation

Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Abramson Cancer Center at Penn Medicine, a pharmaceutical company.

Is this study still recruiting?

The registry lists this study as enrolling by invitation.

Want to explore more studies?

Explore studies